Why Gilead isn't soaring

Now watching

Next video starts in : 7 Play

Why Gilead isn't soaring

Why Gilead isn't soaring
Replay video
Up next

Where big money investors are placing their bets

Unlock your personal NFL Now stream by signing in to NFL.com

Why Gilead isn't soaring

by CNBC Videos 1:52 mins

Gilead Sciences reported Q2 EPS of $2.36 ex-items on revenue of $6.53 billion, with $3.48 billion sales of Sovaldi. CNBC's Meg Tirrell reports the highlights from the conference call.

View Comments (0)